PMID: 9182074Jan 1, 1997Paper

Antioxidant action of Vaccinium myrtillus extract on human low density lipoproteins in vitro: initial observations

Fundamental & Clinical Pharmacology
P M LaplaudM J Chapman

Abstract

Oxidative modifications of low density lipoproteins (LDL) are now recognised as one of the major processes in atherogenesis. Various drugs, as well as a number of natural products, have been proposed to inhibit such processes. Among the naturally-occurring constituents of plants which appear to possess antioxidant activity are polyphenolic compounds such as flavonoids. The aqueous extract of Vaccinium myrtillus is rich in such molecules. In this report, we describe the in vitro antioxidative potential of this extract on human LDL. The copper-induced oxidative modification of these lipoproteins was assessed using 1) measurement of oxidative resistance as determined by the lag-phase preceding conjugated diene formation; 2) quantification of the amount of lipoperoxides and thiobarbituric acid-reactive substances generated, and measurement of the modification in the net negative electrical charge of the lipoproteins, over a 7-hour time course experiment. Trace amounts of V myrtillus extract (15 to 20 micrograms/mL) induce statistically significant changes in the oxidation behaviour of LDL, which include 1) prolongation of the lag-phase of conjugated diene production (P < 0.01); 2) reduction in the formation of lipoperoxides and of ...Continue Reading

References

Jan 1, 1978·Methods in Enzymology·J A Buege, S D Aust
Aug 24, 1976·Biochimica Et Biophysica Acta·J A Buege, S D Aust
Dec 19, 1975·European Journal of Clinical Pharmacology·R GuglerH J Dengler
Dec 1, 1991·The Journal of Clinical Investigation·J L Witztum, D Steinberg
Jun 1, 1990·Biochemical Pharmacology·C V de WhalleyD S Leake
Apr 6, 1989·The New England Journal of Medicine·D SteinbergJ L Witztum
Jul 1, 1995·The Journal of Nutrition·C ManachC Rémésy
Jul 17, 1995·Biochemical and Biophysical Research Communications·L J YanL Packer
Sep 17, 1994·Lancet·J L Witztum
Oct 1, 1993·Biulleten' eksperimental'noĭ biologii i meditsiny·M I DushkinE N Pivovarova
Feb 24, 1996·BMJ : British Medical Journal·P KnektJ Maatela
Dec 1, 1995·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J V Formica, W Regelson
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Citations

Jan 1, 2004·Indian Journal of Clinical Biochemistry : IJCB·Simmi Kharb, Veena Singh
Nov 28, 2002·Pharmacology & Therapeutics·Bent H Havsteen
Jun 8, 2001·Journal of Ethnopharmacology·M I IslaM A Vattuone
Jul 2, 2004·The British Journal of Nutrition·Colin D KayJian Wang
Jun 1, 2006·Nutrition Research Reviews·Colin D Kay
Dec 22, 1998·The American Journal of Cardiology·J P Cooke
Apr 22, 2009·European Child & Adolescent Psychiatry·Robin E Gearing, Alice Charach
Dec 13, 2006·Journal of Fluorescence·Mikko J ParryJuha-Matti Alakoskela
Dec 28, 2007·American Journal of Physiology. Endocrinology and Metabolism·David J LloydMurielle M Véniant
Apr 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Matthew T MazurRonald C Hendrickson
Dec 12, 2002·Journal of Agricultural and Food Chemistry·G MazzaBruce J Holub

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.